Form 4: Stanage Nick L reports multiple insider transactions in HXL
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Stanage Nick L reported multiple insider transaction types in a Form 4 filing for HXL. The filing lists transactions totaling 168,371 shares at a weighted average price of $67.74 per share. Following the reported transactions, holdings were 517,988 shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
61,204 shares exercised/converted
Mixed
3 txns
Insider
Stanage Nick L
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-Qualified Stock Options | 61,204 | $0.00 | -- |
| Exercise | Common Stock | 61,204 | $50.50 | $3.09M |
| Tax Withholding | Common Stock | 45,963 | $90.69 | $4.17M |
Holdings After Transaction:
Non-Qualified Stock Options — 0 shares (Direct);
Common Stock — 517,988 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Hexcel (HXL) director Nick L. Stanage report?
Hexcel director Nick L. Stanage reported exercising 61,204 non-qualified stock options for common stock. The options converted into shares at an exercise price of $50.5 per share on February 12, 2026, as disclosed in a Form 4 insider trading report.
What prices were involved in Nick L. Stanage’s Hexcel (HXL) Form 4 transactions?
The non-qualified stock options were exercised at an exercise price of $50.5 per share. A related tax-withholding disposition of 45,963 Hexcel common shares was reported at a price of $90.69 per share on February 12, 2026.
Was Nick L. Stanage’s Hexcel (HXL) Form 4 an open-market stock sale?
The Form 4 shows no open-market sale. It reports an option exercise coded “M” and a disposition coded “F,” meaning shares were delivered to cover exercise price or tax liabilities, rather than being sold in an ordinary market transaction.
What are the details of the Hexcel (HXL) stock options exercised by Nick L. Stanage?
The exercised derivative security was a non-qualified stock option grant dated January 30, 2018, with an exercise price of $50.5. The filing notes these options vest in equal increments on the first three anniversaries of the original grant date.